carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
Launch of Generic Niaspan® Extended-Release Tablets
Released: 09/24/2013
By: Carl Richie, Pharmacy Manager

Teva Pharmaceuticals has launched generic Niaspan® Extended-Release Tablets, which received FDA Approval in April 2005 and can now be released based on a settlement with the brand manufacturer.

Niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. Estimated annual U.S. brand sales of this product are $1.129 billion.

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer